Cerus reported $18.08M in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Atrion ATRI:US 22.92M 2.15M
Cerus CERS:US $ 18.08M 1.4M
GRIFOLS GRF:SM € 771.1M 119.7M
Haemonetics HAE:US $ 128.73M 7.34M
Meridian Bioscience VIVO:US $ 42.75M 3.57M
Nuvasive NUVA:US $ 79.1M 4.44M
Orasure Technologies OSUR:US $ 43.44M 7M
Quidel QDEL:US $ 262.3M 114.78M
Sientra SIEN:US $ 8.55M 1.77M
Staar Surgical STAA:US $ 13.94M 0.07M
Terumo 4543:JP Y 89321M 3073M
Utah Medical Products UTMD:US 4.5M 482K